CYFRA 21-1 as a tool for distant metastasis detection in lung cancer

Clinical Laboratory

Volumn 57, Issue 11-12, 2011, Pages 1011-1014

  Cabrera Alarcon, J L ^a   Carrillo Vico, A ^a   Santotoribio, J D ^a   Leon Justel, A ^a   Sanchez Gil, R ^a   Gonzalez Castro, A ^a   Guerrero, J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

CYFRA 21 1; Lung cancer; Metastasis; NSCLC; NSE

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; DISTANT METASTASIS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ANTIGENS, NEOPLASM; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; HUMANS; KERATIN-19; LUNG NEOPLASMS; MEMBRANE PROTEINS; MUCIN-1; NEOPLASM PROTEINS; NEOPLASM STAGING; PHOSPHOPYRUVATE HYDRATASE; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 83455236497     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Sider L, Horejs D. Frequency of extrathoracic metastasis from bronchogenic carcinoma in patients with normal-sized hilar and mediastinal lymph nodes on CT. AJR Am J Roentgenol 1988;151:893-5.
2. Stitik FP. Staging of lung cancer. Radiol Clin North Am 1990;28:619-30. (Pubitemid 20124919)
3. Tas F, Aydiner A, Topuz E, Camlica H, Saip P, Eralp Y. Factors influencing the distribution of metastasis and survival in extensive disease small cell lung cancer. Acta Oncol 1999;38:1011-5. (Pubitemid 30033021)
4. Tritz DB, Doll DC, Ringenberg QS, et al. Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables. Cancer 1989;63:763-6. (Pubitemid 19050282)
5. Ebert W, Muley T, Herb KP, Schmidt-Gayk H. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients. Anticancer Res 2004;24:3193-201. (Pubitemid 39390972)
6. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003;123(Suppl):137S-146S. (Pubitemid 36135711)
7. Molina R, Filella X, Ballesta AM. Tumor markers: theory or reality? Med Clin (Barc) 1994;102:189-95.
8. Pujol JL, Boher JM, Grenier J, Quantin X. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients. Lung Cancer 2001;31(2-3):221-31. (Pubitemid 32109238)
9. Brink I, Schumacher T, Mix M, et al. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging 2004;31:1614-20. (Pubitemid 40104607)